Quick Takeaways
- Laura Hamill has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $856,356.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Laura Hamill
- Location
- Paradise Valley, AZ
- Summary
- The estimated net worth of Laura Hamill is at least $856,356 dollars as of 19 Sep 2025. Laura Hamill is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $771.3K. Laura Hamill is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $85.1K.
- Signature
- /s/ John LaRocca, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Laura Hamill and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Jazz Pharmaceuticals plc ($771,297).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Laura Hamill
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | Director | $771,297 | 07 Aug 2025 | ||
| ANAB | ANAPTYSBIO, INC | Director | $85,059 | 06 Jan 2023 | ||
| YMAB | Y-mAbs Therapeutics, Inc. | Director | $0 | 16 Sep 2025 | ||
| XLRN | ACCELERON PHARMA INC | Director | 19 Nov 2021 | |||
| PRDS | PARDES BIOSCIENCES, INC. | Director | 31 Aug 2023 | |||
| SCLX, SCLXW | Scilex Holding Co | Director | 17 Jan 2023 |
Insider Transactions Reported by Laura Hamill:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.